InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+15.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Lacey David L., Director. Director active across 1 company, notably Arcus Biosciences, Inc.. Aggregated, 6 reports have been published. Activity tracked since 3 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
5,700 sharesCommon StockSEC:0001734422-26-000005:0
13,300 shares0Common StockSEC:0001724521-25-000088:0
8,400 shares0Common StockSEC:0001724521-24-000115:0
6,800 shares0Common StockSEC:0001209191-23-038145:0
4,100 shares0Common StockSEC:0001209191-22-037412:0
3,000 shares0Common StockSEC:0001209191-21-038623:0
6 of 6 declarations
About Lacey David L.
David L. Lacey is a Board Member at Arcus Biosciences, Inc. He plays a key role in overseeing the activities and strategy of the company. Lacey is recognized for his expertise in the biotechnology field.
